Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Natus Medical Inc Lowers FY 2012 Revenue Guidance; Lowers High End Of Prior FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates; Issues Q4 2012 Guidance In Line With Analysts' Estimates


Wednesday, 7 Nov 2012 07:00am EST 

Natus Medical Inc updated its fiscal 2012 financial guidance. For fiscal 2012, the Company expects to report revenue of $293 million to $296 million and non-GAAP earnings per share of $0.58 to $0.61. The Company had earlier said that it expected to report revenue of $295 million to $300 million and non-GAAP earnings per share of $0.58 to $0.63. For the fourth quarter of 2012, the Company expects to report revenue of $92 million to $95 million and non-GAAP earnings per share (EPS) of $0.25 to $0.28. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $295 million and EPS of $.60 for fiscal 2012; and revenue of $95 million and EPS of $.28 for the fourth quarter of 2012. 

Company Quote

28.11
0.6 +2.18%
4:00pm EDT